Life Science REIT (LON:LABS) Shares Down 0.3% – Here’s Why

Life Science REIT plc (LON:LABSGet Free Report)’s stock price was down 0.3% on Wednesday . The stock traded as low as GBX 33.20 ($0.41) and last traded at GBX 33.60 ($0.42). Approximately 504,803 shares were traded during trading, a decline of 39% from the average daily volume of 830,460 shares. The stock had previously closed at GBX 33.70 ($0.42).

Analyst Ratings Changes

Separately, Berenberg Bank restated a “buy” rating and set a GBX 57 ($0.71) price objective on shares of Life Science REIT in a research report on Thursday, October 3rd.

View Our Latest Research Report on Life Science REIT

Life Science REIT Trading Down 0.3 %

The business’s 50-day simple moving average is GBX 36.91 and its 200-day simple moving average is GBX 36.62. The company has a market cap of £117.60 million, a PE ratio of -560.00 and a beta of 0.08.

About Life Science REIT

(Get Free Report)

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

Recommended Stories

Receive News & Ratings for Life Science REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life Science REIT and related companies with MarketBeat.com's FREE daily email newsletter.